Abiopharma

News list

Director Larsen Michael M 🟢 acquired 2.3K shares (1 derivative) of SMITH A O CORP (AOS) Transaction Date: Apr 13, 2026 | Filing ID: 000003

Full text

News bot April 15, 2026, 6:52 p.m.
🔍 Larsen Michael M (Director)

Company: SMITH A O CORP (AOS)

Report Date: 2026-04-13
Transaction Summary:
- Total transactions: 2
- Derivative instruments: 1
- Holdings reported: 1
- Total shares acquired: 2,262
- Total shares held: 11,425
Detailed Transactions and Holdings:
- Holds 0 shares of Common Stock (Direct)
  Date: 2026-04-13 | Code: H | shares_owned_after: 11,425.00
- Acquired 2,262 shares of Restricted Stock Units (Derivative)
  Date: 2026-04-13 | Code: A | equity_swap_involved: 0 | shares_owned_after: 13,284.00 | transaction_form_type: 4 | Footnotes: F1, F2, F2, F3
Footnotes:
- F1: Payment of retainer in Restricted Stock Units under the A. O. Smith Nonqualified Deferred Compensation Plan based on the average of the high and the low price of Common Stock on April 13, 2026.
- F2: The Plan permits the participant to defer the receipt of the award, and Mr. Larsen has made a deferral.
- F3: The Restricted Stock Units receive a quarterly dividend pursuant to a dividend reinvestment feature of the A. O. Smith Nonqualified Deferred Compensation Plan. The total amount of the dividends received was 215 units of Restricted Stock Units.